These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17870245)

  • 1. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidates for peptide receptor radiotherapy today and in the future.
    Reubi JC; Mäcke HR; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
    Giblin MF; Veerendra B; Smith CJ
    In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy targeted to cancers through tumoral hormone receptors.
    Schally AV; Nagy A
    Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].
    Schally AV
    An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers.
    Farahani AM; Maleki F; Sadeghzadeh N
    Anticancer Agents Med Chem; 2020; 20(4):402-416. PubMed ID: 31889492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor targeting with
    Rezazadeh F; Sadeghzadeh N
    Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation methods for bombesin analogs containing the (NalphaHis)Ac chelator for 99mTc(CO)3 radiolabeling.
    Brans L; Maes V; García-Garayoa E; Schweinsberg C; Daepp S; Bläuenstein P; Schubiger PA; Schibli R; Tourwé DA
    Chem Biol Drug Des; 2008 Dec; 72(6):496-506. PubMed ID: 19016795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True radiotracers: Cu-64 targeting vectors based upon bombesin peptide.
    Hoffman TJ; Smith CJ
    Nucl Med Biol; 2009 Aug; 36(6):579-85. PubMed ID: 19647163
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides.
    Cai H; Yang H; Xiang B; Li S; Liu S; Wan L; Zhang J; Li Y; Cheng J; Lu X
    Mol Pharm; 2010 Apr; 7(2):586-96. PubMed ID: 20141196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment approaches for prostate cancer based on peptide analogues.
    Stangelberger A; Schally AV; Djavan B
    Eur Urol; 2008 May; 53(5):890-900. PubMed ID: 18201818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
    Behr TM; Béhé M; Becker W
    Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
    Weiner RE; Thakur ML
    Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
    Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
    Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to the therapy of various tumors based on peptide analogues.
    Schally AV
    Horm Metab Res; 2008 May; 40(5):315-22. PubMed ID: 18491250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
    Khan IU; Beck-Sickinger AG
    Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.